Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,768 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00402766 | Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma | completed | Phase 1 | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT00502411 | Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma | completed | Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT00940381 |
| Sirolimus and Cetuximab in Advanced Malignancies |
| completed |
| Phase 1 |
| 165 |
| M.D. Anderson Cancer CenterOTHER |
| 1 |
| Nov 18, 2015 |
| clinicaltrials |
| NCT00941499 | Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab | completed | Phase 1 | 140 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01057264 | HAI Abraxane With Gemcitabine and Bevacizumab | completed | Phase 1 | 78 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01122615 | Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) | completed | Phase 1 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01152203 | Bendamustine and Bevacizumab for Advanced Cancers | completed | Phase 1 | 59 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01178112 | Trientine and Carboplatin in Advanced Malignancies | completed | Phase 1 | 56 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01421173 | Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies | completed | Phase 1 | 78 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01626001 | Imaging Study Compare 4DCT Image | completed | Phase 1 | 52 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01816659 | An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin | terminated | Phase 1 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01880645 | Selective Image Guided Resection of Axillary Lymph Nodes | completed | N/A | 17 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT00980239 | HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver | completed | Phase 1 | 115 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT01087983 | Lapatinib With Sirolimus or Metformin | completed | Phase 1 | 111 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT02599090 | Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Nov 6, 2015 | clinicaltrials |
| NCT01939730 | Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma | completed | Phase 2 | 42 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 4, 2015 | clinicaltrials |
| NCT00299156 | Oral Clofarabine Study in Patients With Myelodysplastic Syndrome | completed | Phase 2 | 65 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 3, 2015 | clinicaltrials |
| NCT00448019 | FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL) | completed | Phase 2 | 64 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 2, 2015 | clinicaltrials |
| NCT00479089 | Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer | terminated | Phase 2 | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 2, 2015 | clinicaltrials |
| NCT00872157 | BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets | completed | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 23, 2015 | clinicaltrials |
| NCT00345709 | Elizabeth Registry for Low Grade Ovarian Cancer | completed | — | 60 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT00658281 | Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer Patients | completed | — | 28 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT01054313 | Docetaxel and Sirolimus in Patients With Advanced Malignancies | completed | Phase 1 | 103 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT01295931 | Nuclear and Near-Infrared (NIR) Imaging in Melanoma | completed | Phase 1 | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT00038610 | Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia | completed | Phase 2 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 18, 2015 | clinicaltrials |
| NCT00476580 | Health Habits and Cancer Risk Comparison Among Migrant Sri Lankans and Sri Lankans | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 2 | Aug 28, 2015 | clinicaltrials |
| NCT00759603 | Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia | completed | Phase 2 | 60 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 27, 2015 | clinicaltrials |
| NCT00446173 | Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 25, 2015 | clinicaltrials |
| NCT00895128 | Study of Erlotinib in Combination With Dasatinib | completed | Phase 1 | 65 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 13, 2015 | clinicaltrials |
| NCT00895362 | Erlotinib in Combination With Cetuximab | completed | Phase 1 | 65 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 13, 2015 | clinicaltrials |
| NCT00895687 | Study of Erlotinib in Combination With Bortezomib | completed | Phase 1 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 13, 2015 | clinicaltrials |
| NCT00903734 | An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status | completed | Phase 1 | 16 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 13, 2015 | clinicaltrials |
| NCT00386620 | Spousal Relationships and Pain in Metastatic Breast Cancer | completed | — | 548 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 7, 2015 | clinicaltrials |
| NCT00610181 | Magnetic Resonance Imaging in Patients With Breast Cancer | completed | — | 96 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 1, 2015 | clinicaltrials |
| NCT00413478 | 5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia | terminated | Phase 2 | 9 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 30, 2015 | clinicaltrials |
| NCT00905034 | Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage | completed | Phase 2 | 37 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 29, 2015 | clinicaltrials |
| NCT00954941 | Ondansetron Versus Aprepitant Plus Ondansetron for Emesis | completed | Phase 2 | 100 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 25, 2015 | clinicaltrials |
| NCT00771602 | Alemtuzumab + Rituximab Consolidation in CLL | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 23, 2015 | clinicaltrials |
| NCT01531998 | Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM) | completed | Phase 1 / Phase 2 | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 19, 2015 | clinicaltrials |
| NCT01204788 | Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 10, 2015 | clinicaltrials |
| NCT01562301 | Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC) | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jun 8, 2015 | clinicaltrials |
| NCT00500240 | Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) | terminated | Phase 3 | 52 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT00082719 | Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium | completed | Phase 1 | 33 | M.D. Anderson Cancer CenterOTHER | 1 | May 14, 2015 | clinicaltrials |
| NCT00493571 | Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes | completed | Phase 1 | 16 | M.D. Anderson Cancer CenterOTHER | 1 | May 13, 2015 | clinicaltrials |
| NCT00402558 | Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | completed | Phase 1 | 15 | M.D. Anderson Cancer CenterOTHER | 1 | May 8, 2015 | clinicaltrials |
| NCT01433302 | Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass | completed | — | 21 | M.D. Anderson Cancer CenterOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT01392170 | Pegasys in Patients With Chronic Myeloid Leukemia (CML) | terminated | Phase 2 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | May 4, 2015 | clinicaltrials |
| NCT00500110 | Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer | completed | Phase 2 | 39 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 28, 2015 | clinicaltrials |
| NCT00506922 | Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT | completed | Phase 1 / Phase 2 | 150 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 28, 2015 | clinicaltrials |
| NCT02420587 | AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 20, 2015 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials